The Menopausal Transition and Cardiovascular Risk

Obstetrics and Gynecology Clinics of North America

Volumn 38, Issue 3, 2011, Pages 477-488

  Chae, Claudia U ^a   Derby, Carol A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Blood pressure; Diabetes; Lipids; Menopause; Metabolic syndrome; Perimenopause

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; TRIACYLGLYCEROL;

AGING; ALCOHOL CONSUMPTION; ATHEROSCLEROSIS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; DIASTOLIC BLOOD PRESSURE; DIET; ETHNICITY; FOLLOW UP; HORMONAL THERAPY; HUMAN; LIFESPAN; MENOPAUSAL SYNDROME; MENOPAUSE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ATHEROSCLEROSIS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HEALTH SURVEYS; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; PERIMENOPAUSE;

EID: 80053291853     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2011.05.005     Document Type: Review

References (71)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
2. Atsma F., Bartelink M.L., Grobbee D.E., et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006, 13:265-279.
3. Bittner V. Menopause, age, and cardiovascular risk: a complex relationship. J Am Coll Cardiol 2009, 54:2374-2375.
4. Sowers M.F., Crawford S., Sternfeld B., et al. Design, survey sampling and recruitment methods of SWAN: a multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition. Menopause 2000, 175-188. Academic Press, New York (NY). R. Lobos, R. Marcus, J.L. Kelsey (Eds.).
5. Matthews K.A., Kelsey S.F., Meilahn E.N., et al. Educational attainment and behavioral and biologic risk factors for coronary heart disease in middle-aged women. Am J Epidemiol 1989, 129:1132-1144.
6. Dennerstein L., Smith A.M.A., Morse C., et al. Menopausal symptoms in Australian women. Med J Aust 1994, 159:232-236.
7. Roche A.F. Growth, maturation, and body composition: the Fels Longitudinal Study, 1929-1991 1991, Cambridge University Press, Cambridge (UK).
8. Lee Y., Lin R.S., Sung F.C., et al. Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 2000, 53:838-846.
9. Derby C.A. Cardiovascular pathophysiology. Menopause 2000, 229-243. Academic Press, New York (NY). R. Lobos, R. Marcus, J.L. Kelsey (Eds.).
10. Torng P.L., Su T.C., Sung F.C., et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight-the Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2002, 161:409-415.
11. Zhou J.L., Lin S.Q., Shen Y., et al. Serum lipid profile changes during the menopausal transition in Chinese women: a community-based cohort study. Menopause 2010, 17:997-1003.
12. Schubert C.M., Rogers N.L., Remsberg K.E., et al. Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: The Fels Longitudinal Study. Int J Obes (Lond) 2006, 30:251-260.
13. Do K.A., Green A., Guthrie J.R., et al. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am J Epidemiol 2000, 151:584-593.
14. Gold E.B., Bromberger J., Crawford S., et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001, 153:865-874.
15. Derby C.A., Crawford S.L., Pasternak R.C., et al. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol 2009, 169:1352-1361.
16. Matthews K.A., Crawford S.L., Chae C.U., et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol 2009, 54:2366-2373.
17. Matthews K.A., Kuller L.H., Sutton-Tyrrell K., et al. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001, 32:1104-1111.
18. Andrikoula M., McDowell I.F. The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab 2008, 10:271-278.
19. Woodard G.A., Brooks M.M., Barinas-Mitchell E., et al. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause Nov 19, 2010, [Epub ahead of print].
20. Mora S., Otvos J.D., Rifai N., et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009, 119:931-939.
21. Matthews K.A., Kuller L.H., Chang Y., et al. Premenopausal risk factors for coronary and aortic calcification: a 20-year follow-up in the Healthy Women Study. Prev Med 2007, 45:302-308.
22. Kuller L.H., Matthews K.A., Sutton-Tyrrell K., et al. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the Healthy Women Study. Arterioscler Thromb Vasc Biol 1999, 19:2189-2198.
23. Kuller L.H., Simkin-Silverman L.R., Wing R.R., et al. Women's Healthy Lifestyle Project: a randomized clinical trial: results at 54 months. Circulation 2001, 103:32-37.
24. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999, 340:1801-1811.
25. Barton M., Meyer M.R. Postmenopausal hypertension: mechanisms and therapy. Hypertension 2009, 54:11-18.
26. Burt V.L., Whelton P., Roccella E.J., et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
27. Izumi Y., Matsumoto K., Ozawa Y., et al. Effect of age at menopause on blood pressure in postmenopausal women. Am J Hypertens 2007, 20:1045-1050.
28. Shaw L.J., Bairey Merz C.N., Azziz R., et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008, 93:1276-1284.
29. Mercuro G., Zoncu S., Saiu F., et al. Menopause induced by oophorectomy reveals a role of ovarian estrogen on the maintenance of pressure homeostasis. Maturitas 2004, 47:131-138.
30. Ong K.L., Cheung B.M., Man Y.B., et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007, 49:69-75.
31. Portaluppi F., Pansini F., Manfredini R., et al. Relative influence of menopausal status, age, and body mass index on blood pressure. Hypertension 1997, 29:976-979.
32. Zanchetti A., Facchetti R., Cesana G.C., et al. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 2005, 23:2269-2276.
33. Sutton-Tyrrell K., Wildman R.P., Matthews K.A., et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005, 111:1242-1249.
34. Collins P., Rosano G., Casey C., et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 2007, 28:2028-2040.
35. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
36. Derby C.A., FitzGerald G., Lasser N.L., et al. Application of national screening criteria for blood pressure and cholesterol to perimenopausal women: prevalence of hypertension and hypercholesterolemia in the Study of Women's Health Across the Nation. Prev Cardiol 2006, 9:150-159.
37. Lloyd-Jones D.M., Sutton-Tyrrell K., Patel A.S., et al. Ethnic variation in hypertension among premenopausal and perimenopausal women: Study of Women's Health Across the Nation. Hypertension 2005, 46:689-695.
38. Guthrie J.R., Ball M., Dudley E.C., et al. Impaired fasting glycaemia in middle-aged women: a prospective study. Int J Obes Relat Metab Disord 2001, 25:646-651.
39. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007, 92:399-404.
40. Janssen I., Powell L.H., Crawford S., et al. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 2008, 168:1568-1575.
41. Torrens J.I., Sutton-Tyrrell K., Zhao X., et al. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: Study of Women's Health Across the Nation. Menopause 2009, 16:257-264.
42. Brand J.S., van der Tweel I., Grobbee D.E., et al. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol 2011, 40:189-207.
43. Polotsky H.N., Polotsky A.J. Metabolic implications of menopause. Semin Reprod Med 2010, 28:426-434.
44. Rosano G.M., Chierchia S.L., Leonardo F., et al. Cardioprotective effects of ovarian hormones. Eur Heart J 1996, 17(Suppl D):15-19.
45. Samaan S.A., Crawford M.H. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol 1995, 26:1403-1410.
46. Kublickiene K., Luksha L. Gender and the endothelium. Pharmacol Rep 2008, 60:49-60.
47. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002, 89:12E-17E.
48. Gupta S., Rymer J. Hormone replacement therapy and cardiovascular disease. Int J Gynaecol Obstet 1996, 52:119-125.
49. Collins P., Rosano G.M., Jiang C., et al. Cardiovascular protection by oestrogen-a calcium antagonist effect?. Lancet 1993, 341:1264-1265.
50. Glasser S.P., Selwyn A.P., Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am Heart J 1996, 131:379-384.
51. Wild R.A. Estrogen: effects on the cardiovascular tree. Obstet Gynecol 1996, 87:27S-35S.
52. Celermajer D.S., Sorensen K.E., Bull C., et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994, 24:1468-1474.
53. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994, 24:471-476.
54. Taddei S., Virdis A., Ghiadoni L., et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996, 28:576-582.
55. Jensen-Urstad K., Johansson J. Gender difference in age-related changes in vascular function. J Intern Med 2001, 250:29-36.
56. Thurston R.C., Sutton-Tyrrell K., Everson-Rose S.A., et al. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008, 118:1234-1240.
57. Wildman R.P., Colvin A.B., Powell L.H., et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008, 15:414-421.
58. Thurston R.C., Sutton-Tyrrell K., Everson-Rose S.A., et al. Hot flashes and carotid intima media thickness among midlife women. Menopause Jan 14, 2011, [Epub ahead of print].
59. Sibley C., Blumenthal R.S., Merz C.N., et al. Limitations of current cardiovascular disease risk assessment strategies in women. J Womens Health (Larchmt) 2006, 15:54-56.
60. D'Agostino R.B.S., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
61. Barrett-Connor E. Hormones and heart disease in women: the timing hypothesis. Am J Epidemiol 2007, 166:506-510.
62. Manson J.E., Bassuk S.S. Invited commentary: Hormone therapy and risk of coronary heart disease-why renew the focus on the early years of menopause?. Am J Epidemiol 2007, 166:511-517.
63. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
64. Anderson G.L., Limacher M., Assaf A.R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291:1701-1712.
65. Mikkola T.S., Clarkson T.B. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002, 53:605-619.
66. Grodstein F., Manson J.E., Stampfer M.J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) 2006, 15:35-44.
67. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297:1465-1477.
68. Salpeter S.R., Walsh J.M., Greyber E., et al. Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med 2006, 21:363-366.
69. Prentice R.L., Manson J.E., Langer R.D., et al. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol 2009, 170:12-23.
70. LaCroix A.Z., Chlebowski R.T., Manson J.E., et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011, 305:1305-1314.
71. Miller V.M., Black D.M., Brinton E.A., et al. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res 2009, 2:228-239.